Renal angiomyolipoma with tuberous sclerosis complex

Renal angiomyolipoma with tuberous sclerosis complex refers to the development of benign mesenchymal hamartomatous tumors of the kidneys in individuals with the genetic neurocutaneous disorder tuberous sclerosis complex Driven by inactivating mutations in either the *TSC1* or *TSC2* tumor suppressor genes, loss of downstream regulation triggers constitutive hyperactivation of the mammalian target of rapamycin (mTOR) signaling pathway, resulting in abnormal cellular proliferation

Renal angiomyolipoma with tuberous sclerosis complex refers to the development of benign mesenchymal hamartomatous tumors of the kidneys in individuals with the genetic neurocutaneous disorder tuberous sclerosis complex Driven by inactivating mutations in either the *TSC1* or *TSC2* tumor suppressor genes, loss of downstream regulation triggers constitutive hyperactivation of the mammalian target of rapamycin (mTOR) signaling pathway, resulting in abnormal cellular proliferation Unlike sporadic ...

Unlike sporadic renal lesions, tumors in this patient population are typically bilateral, multifocal, fast-growing, and present at an earlier age Histopathologically composed of dysplastic blood vessels, smooth muscle-like cells, and mature adipose tissue, these lesions carry significant risks of aneurysm formation, retroperitoneal hemorrhage, hematuria, flank pain, and progressive loss of functional renal parenchyma

Unlike sporadic renal lesions, tumors in this patient population are typically bilateral, multifocal, fast-growing, and present at an earlier age

Histopathologically composed of dysplastic blood vessels, smooth muscle-like cells, and mature adipose tissue, these lesions carry significant risks of aneurysm formation, retroperitoneal hemorrhage, hematuria, flank pain, and progressive loss of functional renal parenchyma